Loading...
Lesson of the month 1: Septic arthritis with normal acute phase reactants and white cell count in a patient receiving tocilizumab
Septic arthritis represents 8–27% of cases of monoarthritis presenting to the emergency department. Tocilizumab is an interleukin-6 blocking monoclonal antibody with the mechanistic potential to interfere with the body's normal inflammatory response to an infectious insult. We present a case of...
Na minha lista:
| Udgivet i: | Clin Med (Lond) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Royal College of Physicians
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6297569/ https://ncbi.nlm.nih.gov/pubmed/28572233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.17-3-280 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|